Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Dolby Laboratories (NYSE: DLB ) saw its top and bottom lines both slide in its second fiscal quarter. In its just-released Q2 2013 results, revenue totaled $249 million, down from the $263 million in the same period the previous year. GAAP attributable net profit also dropped, to $62 million ($0.60 per diluted share) from Q2 2012's figure of $88 million ($0.81).
Analysts had been expecting revenue of $246 million and EPS of $0.68.
Dolby also provided forward guidance. For its current quarter, the company believes its revenue will be $205 million to $215 million, with diluted EPS coming in at $0.26 to $0.32. The top line for the full year 2013 is expected to be $910 million-$940 million, with operating expenses coming in at roughly $572 million. Dolby did not provide an EPS estimate.